The second ER protein, ER-beta, is either not expressed in breast cancer or expressed at levels too low for detection by traditional methods (Monteiro et al. 2024) and as such, ER-alpha (from herein ER) is the more abundant and clinically validated ER in this disease. Here, ESR1 is linked to breast carcinoma.